Vizimpro
Product Images NDC 63539-197

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vizimpro (NDC 63539-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vizimpro 01)

FDA Label Image

Figure 1 (Vizimpro 02)

Figure 1 (Vizimpro 02)
This is a chart that shows the Probability of Progression-Free Survival for two drugs, VIZIMPRO and Geftino. The numbers represent the number of patients in each group and their progression-free survival in months. The lower values on the chart indicate the number of patients at each interval. There are some censored patients in the VIZIMPRO group.*
FDA Label Image

Figure 2 (Vizimpro 03)

Figure 2 (Vizimpro 03)
This appears to be a chart showing Overall Survival for two different treatments: vizmpRO and Gefitinib. It shows the number of patients at risk and the months survived for each treatment. The data is censored, meaning not all outcomes are known.*
FDA Label Image

Logo (Vizimpro 04)

Logo (Vizimpro 04)
This text is a statement indicating the distributing company for a product. The name of the company is Pfizer Labs, which is a division of Pfizer Inc, located in NY with zip code 10017.*
FDA Label Image

Logo (Vizimpro 05)

Logo (Vizimpro 05)
This text is a brief description of a division of Pfizer Inc, called Pfizer Labs, and its distribution activities.*
FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Principal Display Panel (15 mg Tablet Bottle Label)
This text provides storage instructions and dosage information for Vizimpro, a tablet medication containing 15 mg of dacomitinib. It instructs to store the medication between 20°C to 25°C and dispense in tight, child-resistant containers. The medication is distributed by U.S. Pharmaceuticals Piizer Inc and is made in Ireland. The text also includes a professional sample disclaimer and reference to the accompanying prescribing information. The product is not for sale and the given NDC and code are for identification purposes only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.